Terms: = Kidney tumors AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575
22 results:
1. Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
Schoenfeld DA; Moutafi M; Martinez S; Djureinovic D; Merkin RD; Adeniran A; Braun DA; Signoretti S; Choueiri TK; Parisi F; Hurwitz M; Rimm DL; Wei W; Jilaveanu L; Kluger HM
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586773
[TBL] [Abstract] [Full Text] [Related]
2. Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.
Lee MH; Theodoropoulos J; Huuhtanen J; Bhattacharya D; Järvinen P; Tornberg S; Nísen H; Mirtti T; Uski I; Kumari A; Peltonen K; Draghi A; Donia M; Kreutzman A; Mustjoki S
Cancer Res Commun; 2023 Jul; 3(7):1260-1276. PubMed ID: 37484198
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.
Lv S; Tao L; Liao H; Huang Z; Lu Y
Funct Integr Genomics; 2023 Jun; 23(2):193. PubMed ID: 37264263
[TBL] [Abstract] [Full Text] [Related]
4. Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort.
Stoltze UK; Hildonen M; Hansen TVO; Foss-Skiftesvik J; Byrjalsen A; Lundsgaard M; Pignata L; Grønskov K; Tumer Z; Schmiegelow K; Brok JS; Wadt KAW
J Med Genet; 2023 Sep; 60(9):842-849. PubMed ID: 37019617
[TBL] [Abstract] [Full Text] [Related]
5. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
[TBL] [Abstract] [Full Text] [Related]
6. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
7. [Expression of regulatory T cells and natural killer T cells in peripheral blood of children with Wilms tumor].
Chen J; Lin T
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1222-1226. PubMed ID: 27974111
[TBL] [Abstract] [Full Text] [Related]
8. The immune phenotype may relate to cancer development in kidney transplant recipients.
Hope CM; Grace BS; Pilkington KR; Coates PT; Bergmann IP; Carroll RP
Kidney Int; 2014 Jul; 86(1):175-83. PubMed ID: 24429406
[TBL] [Abstract] [Full Text] [Related]
9. Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
Carroll RP; Hester J; Wood KJ; Harden PN
Nephrol Dial Transplant; 2013 Feb; 28(2):462-5. PubMed ID: 23223314
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-infiltrating regulatory T cells are positively correlated with angiogenic status in renal cell carcinoma.
Ning H; Shao QQ; Ding KJ; Gao DX; Lu QL; Cao QW; Niu ZH; Fu Q; Zhang CH; Qu X; Lü JJ
Chin Med J (Engl); 2012 Jun; 125(12):2120-5. PubMed ID: 22884140
[TBL] [Abstract] [Full Text] [Related]
11. Thymic function, anti-thymocytes globulins, and cancer after renal transplantation.
Ducloux D; Bamoulid J; Courivaud C; Gaugler B; Rebibou JM; Ferrand C; Chalopin JM; Borg C; Tiberghien P; Saas P
Transpl Immunol; 2011 Jul; 25(1):56-60. PubMed ID: 21620972
[TBL] [Abstract] [Full Text] [Related]
12. Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.
Desar IM; Jacobs JH; Hulsbergen-vandeKaa CA; Oyen WJ; Mulders PF; van der Graaf WT; Adema GJ; van Herpen CM; de Vries IJ
Int J Cancer; 2011 Jul; 129(2):507-12. PubMed ID: 20839259
[TBL] [Abstract] [Full Text] [Related]
13. Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.
Carroll RP; Segundo DS; Hollowood K; Marafioti T; Clark TG; Harden PN; Wood KJ
J Am Soc Nephrol; 2010 Apr; 21(4):713-22. PubMed ID: 20110382
[TBL] [Abstract] [Full Text] [Related]
14. Frequency and gene expression profile of regulatory T cells in renal cell carcinoma.
Jeron A; Pfoertner S; Bruder D; Geffers R; Hammerer P; Hofmann R; Buer J; Schrader AJ
Tumour Biol; 2009; 30(3):160-70. PubMed ID: 19609102
[TBL] [Abstract] [Full Text] [Related]
15. The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy.
Lehe C; Ghebeh H; Al-Sulaiman A; Al Qudaihi G; Al-Hussein K; Almohareb F; Chaudhri N; Alsharif F; Al-Zahrani H; Tbakhi A; Aljurf M; Dermime S
Cancer Res; 2008 Aug; 68(15):6350-9. PubMed ID: 18676860
[TBL] [Abstract] [Full Text] [Related]
16. LINAC radiosurgery for brain metastasis of renal cell carcinoma.
Noel G; Valery CA; Boisserie G; Cornu P; Hasboun D; Marc Simon J; Tep B; Ledu D; Delattre JY; Marsault C; Baillet F; Mazeron JJ
Urol Oncol; 2004; 22(1):25-31. PubMed ID: 14969800
[TBL] [Abstract] [Full Text] [Related]
17. Preliminary experience with cryoablation of renal lesions smaller than 4 centimeters.
Khorsandi M; Foy RC; Chong W; Hoenig DM; Cohen JK; Rukstalis DB
J Am Osteopath Assoc; 2002 May; 102(5):277-81. PubMed ID: 12033757
[TBL] [Abstract] [Full Text] [Related]
18. Partial nephrectomy for renal tumours: the Singapore General Hospital experience.
Yip SK; Cheng WS; Tan BS; Li MK; Foo KT
J R Coll Surg Edinb; 1999 Jun; 44(3):156-60. PubMed ID: 10372483
[TBL] [Abstract] [Full Text] [Related]
19. Phenotypic and functional characterization of mast cells derived from renal tumor tissues.
Beil WJ; Füreder W; Wiener H; Grossschmidt K; Maier U; Schedle A; Bankl HC; Lechner K; Valent P
Exp Hematol; 1998 Feb; 26(2):158-69. PubMed ID: 9472805
[TBL] [Abstract] [Full Text] [Related]
20. High-dose toremifene in advanced renal-cell carcinoma.
Gershanovich MM; Moiseyenko VM; Vorobjev AV; Käpylä H; Ellmén J; Anttila M
Cancer Chemother Pharmacol; 1997; 39(6):547-51. PubMed ID: 9118468
[TBL] [Abstract] [Full Text] [Related]
[Next]
